Remarkable and persistent shrinkage of uterine leiomyoma associated with interferon alfa treatment for hepatitis.
Minakuchi
K
K
Kawamura
N
N
Tsujimura
A
A
Ogita
S
S
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007889:Leiomyoma / Q000150:complications / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000150:complications / Q000188:drug therapy*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D016898:Interferon-alpha